Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case–control study

BACKGROUND: Annually, colorectal cancer (CRC) is diagnosed in >1.4 million subjects worldwide and incidence is increasing. Much effort has therefore been focused on screening, which has proven to reduce cancer-related mortality. The Sept9 DNA-methylation assay is among the most well studied blood...

Descripción completa

Detalles Bibliográficos
Autores principales: Ørntoft, Mai-Britt W., Nielsen, Hans J., Ørntoft, Torben F., Andersen, Claus L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625973/
https://www.ncbi.nlm.nih.gov/pubmed/26514170
http://dx.doi.org/10.1186/s12885-015-1832-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625973/
https://www.ncbi.nlm.nih.gov/pubmed/26514170
http://dx.doi.org/10.1186/s12885-015-1832-6

Ejemplares similares